AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

NCT00397878 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

NIH

Sponsor class

Stopped The study was terminated after all enrolled participants progressed.

Conditions

Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: saracatinib
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)